Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Strack

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 26, 2010
The pharmacokinetics of alternative insulin delivery systemsThomas Strack
Drugs of Today (Barcelona, Spain : 1998)|November 8, 2007
Imaging as a tool in drug developmentThomas Strack
Journal of Clinical Epidemiology|November 3, 2009
Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trialsNick Freemantle, Thomas Strack
Diabetes Technology & Therapeutics|June 23, 2009
Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetesMarcus Hompesch, Alexa Kollmeier, Klaus Rave, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or ParagangliomaRichard B Noto, Daniel A Pryma, Jessica Jensen, et al.
Cancer Investigation|January 19, 2023
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell LymphomaChenyu Lin, Ahmed Galal, David Rizzieri, et al.
Journal of Medicinal Chemistry|February 17, 2006
Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studiesKatharina J Guenther, Sabesan Yoganathan, Robert Garofalo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
Phase 2 Study of <sup>99m</sup>Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN DissectionKarolien E Goffin, Steven Joniau, Peter Tenke, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial designThomas Strack, Luc Martinez, Stefano Del Prato, et al.
Cancer Research Communications|March 6, 2023
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell LymphomaPaul A Hamlin, Vasile Musteata, Steven I Park, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|March 26, 2010
The pharmacokinetics of alternative insulin delivery systemsThomas Strack
Drugs of Today (Barcelona, Spain : 1998)|November 8, 2007
Imaging as a tool in drug developmentThomas Strack
Journal of Clinical Epidemiology|November 3, 2009
Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trialsNick Freemantle, Thomas Strack
Diabetes Technology & Therapeutics|June 23, 2009
Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetesMarcus Hompesch, Alexa Kollmeier, Klaus Rave, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2017
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or ParagangliomaRichard B Noto, Daniel A Pryma, Jessica Jensen, et al.
Cancer Investigation|January 19, 2023
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell LymphomaChenyu Lin, Ahmed Galal, David Rizzieri, et al.
Journal of Medicinal Chemistry|February 17, 2006
Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studiesKatharina J Guenther, Sabesan Yoganathan, Robert Garofalo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
Phase 2 Study of <sup>99m</sup>Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN DissectionKarolien E Goffin, Steven Joniau, Peter Tenke, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial designThomas Strack, Luc Martinez, Stefano Del Prato, et al.
Cancer Research Communications|March 6, 2023
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell LymphomaPaul A Hamlin, Vasile Musteata, Steven I Park, et al.
Pageof 2